NEW YORK, Nov. 29, 2021 /PRNewswire/ — The “Dental Bone Graft Substitutes Market – Competitive Analysis, Drivers, Challenges and Five Force Analysis” report has been added to Technavio’s offering. The dental bone graft substitutes market is estimated to grow by USD 264.60 million from 2020 to 2025. However, the growth momentum is likely to decelerate at a CAGR of 6.40%.
For more insights on the Dental Bone Graft Substitutes Market –Download a free sample now!
37% of the market’s growth will originate from Europe. France and Germany are the key markets for dental bone graft substitutes in the region. The rising investment in clinical trials will facilitate the dental bone graft substitutes market growth in Europe. The report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for vendors.
Market Dynamics
Factors such as the increasing incidence of oral diseases and the rising edentulous population will drive the growth of the Dental Bone Graft Substitutes Market. However, the high cost of dental bone graft procedures might hamper the market growth. The dental bone graft substitutes market analysis report also provides detailed information on other upcoming trends that will have a far-reaching effect on the market growth.
Company Profiles
The dental bone graft substitutes market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. Some of the companies covered in this report are BioHorizons Inc., Biomatlante SAS, Botiss Biomaterials GmbH, DENTSPLY SIRONA Inc., Exactech Inc., Geistlich Pharma AG, Medtronic Plc, RTI Surgical Inc., Straumann Holding AG, and Zimmer Biomet Holdings Inc., etc.
Few Companies with Key Offerings
-
BioHorizons Inc. – The company offers dental bone graft substitutes that form an osteoconductive scaffold for volume enhancement and effective site development to place dental and other bone implants, under the brand name of MinerOss and Grafton.
-
Biomatlante SAS – The company offers a dental bone graft substitute named MBCP, a biphasic calcium phosphate synthetic bone graft substitute with a micro and macroporous structure that most closely resemble the architecture of natural human bone and it gradually dissolves in the body, promoting new bone formation through the release of calcium and phosphate ions, under the brand name of BioMatlante.
-
Botiss Biomaterials GmbH – The company offers dental bone graft substitutes that enable complex horizontal and vertical augmentation by using the latest 3D CAD and CAM technology where the perfect three-dimensional precision fit significantly reduces valuable surgery time, making autologous bone harvesting and manual adjustment unnecessary, under the brand name of Biotiss.
Competitive Analysis
The competitive scenario provided in the dental bone graft substitutes market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product